PLUS1
5.10
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| ESSA Pharma Inc | EPIX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.06 | -1.16% | 5.10 | 5.10 | 5.39 | 5.25 | 5.16 | 16:00:04 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.0001 | 4,294.67 | 4,294.67 | 100.0% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 234 | 46,023 | $ 5.24 | $ 241,341 | 25,227 | 1.41 - 6.1372 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 100 | $ 5.10 | USD |
ESSA Pharma Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 106.21M | 20.82M | 13.48M | $ - | $ - | -1.24 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
ESSA Pharma News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/27/2020 | 08:38 | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) |
| 5/27/2020 | 07:00 | PR Newswire (US) | ESSA Pharma to Present at Jefferies Virtual Healthcare.. |
| 5/15/2020 | 08:35 | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) |
| 5/15/2020 | 07:30 | PR Newswire (US) | ESSA Pharma Presents Therapeutic Potential of EPI-7386 at.. |
| 5/07/2020 | 17:33 | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) |
| 5/07/2020 | 17:05 | PR Newswire (Canada) | ESSA Pharma Provides Corporate Update and Reports Financial.. |
| 5/01/2020 | 06:26 | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EPIX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.20 | 5.4792 | 5.10 | 5.18 | 12,863 | -0.10 | -1.92% |
| 1 Month | 4.50 | 5.4855 | 4.31 | 4.93 | 23,540 | 0.60 | 13.33% |
| 3 Months | 4.47 | 5.4855 | 3.00 | 4.27 | 23,806 | 0.63 | 14.09% |
| 6 Months | 5.60 | 6.1372 | 3.00 | 4.94 | 30,740 | -0.50 | -8.93% |
| 1 Year | 2.40 | 6.1372 | 1.41 | 4.13 | 32,011 | 2.70 | 112.5% |
| 3 Years | 2.01 | 6.1372 | 0.10 | 1.28 | 56,798 | 3.09 | 153.73% |
| 5 Years | 8.30 | 11.69 | 0.10 | 1.38 | 40,787 | -3.20 | -38.55% |
ESSA Pharma Description
| ESSA Pharma Inc is a pharmaceutical company. The company is in preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs which selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. |
